| Lastest Insider Transactions Of Aclaris Therapeutics, Inc. ( ACRS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2026-04-27 | Sell | 300,000 | 4.53 | 1,359,000 | 2026-04-27 19:27:01 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2026-02-03 | Option Exercise | 20,875 | 0.00 | 0 | 2026-02-05 16:48:42 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO | 2026-02-03 | Option Exercise | 63,475 | 0.00 | 0 | 2026-02-05 16:45:57 |
| ACRS | Aclaris Therapeutics, Inc. | Davis Hugh M. | President and COO | 2026-02-03 | Option Exercise | 18,675 | 0.00 | 0 | 2026-02-05 16:44:00 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2026-02-03 | Option Exercise | 22,025 | 0.00 | 0 | 2026-02-05 16:41:46 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2026-02-01 | Option Exercise | 33,500 | 0.00 | 0 | 2026-02-05 16:38:04 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2026-02-01 | Option Exercise | 14,750 | 0.00 | 0 | 2026-02-03 17:36:49 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO | 2026-01-02 | Option Exercise | 29,150 | 0.00 | 0 | 2026-01-05 16:32:24 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2025-12-31 | Option Exercise | 94,450 | 0.00 | 0 | 2026-01-05 16:27:39 |
| ACRS | Aclaris Therapeutics, Inc. | Davis Hugh M. | President and COO | 2025-12-02 | Option Exercise | 26,750 | 0.00 | 0 | 2025-12-04 16:50:45 |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:31 |
| ACRS | Aclaris Therapeutics, Inc. | MILANO VINCENT | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:29 |
| ACRS | Aclaris Therapeutics, Inc. | Mehra Anand | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:24 |
| ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:18 |
| ACRS | Aclaris Therapeutics, Inc. | GOWEN MAXINE | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:16 |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Directior | 2025-06-05 | Option Exercise | 4,793 | 0.00 | 0 | 2025-06-09 16:20:12 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO | 2025-05-01 | Option Exercise | 9,467 | 0.00 | 0 | 2025-05-05 16:20:04 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2024-12-31 | Option Exercise | 91,130 | 0.00 | 0 | 2025-01-03 18:25:12 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2024-12-31 | Option Exercise | 94,450 | 0.00 | 0 | 2025-01-03 18:25:10 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2024-12-31 | Option Exercise | 91,900 | 0.00 | 0 | 2025-01-03 18:25:07 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO | 2025-01-01 | Option Exercise | 38,616 | 0.00 | 0 | 2025-01-03 18:25:05 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO | 2024-12-04 | Option Exercise | 118,840 | 1.52 | 180,637 | 2024-12-06 16:15:10 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO | 2024-12-01 | Option Exercise | 9,466 | 0.00 | 0 | 2024-12-03 16:15:11 |
| ACRS | Aclaris Therapeutics, Inc. | Mehra Anand | Directior | 2024-11-19 | Buy | 666,666 | 2.25 | 1,499,999 | 2024-11-20 16:20:04 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | 2024-11-01 | Option Exercise | 9,467 | 0.00 | 0 | 2024-11-05 16:20:05 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | 2024-08-09 | Option Exercise | 43,548 | 0.72 | 31,355 | 2024-08-13 16:15:05 |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-07-18 | Buy | 154,722 | 1.30 | 201,808 | 2024-07-22 16:03:02 |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-07-02 | Buy | 352,397 | 1.15 | 405,894 | 2024-07-05 14:46:52 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | 2024-07-01 | Option Exercise | 9,467 | 0.00 | 0 | 2024-07-03 16:15:15 |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-06-27 | Buy | 1,543,434 | 1.13 | 1,742,075 | 2024-07-01 13:39:08 |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-06-14 | Buy | 545,000 | 1.15 | 628,206 | 2024-06-18 16:04:29 |
| ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-06-11 | Buy | 1,611,200 | 1.11 | 1,781,897 | 2024-06-13 18:04:27 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | 2024-06-01 | Option Exercise | 9,466 | 0.00 | 0 | 2024-06-04 16:30:26 |
| ACRS | Aclaris Therapeutics, Inc. | Reasons Bryan M. | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:22 |
| ACRS | Aclaris Therapeutics, Inc. | Powell Andrew Kenneth William | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:21 |
| ACRS | Aclaris Therapeutics, Inc. | MILANO VINCENT | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:18 |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:18 |
| ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:16 |
| ACRS | Aclaris Therapeutics, Inc. | GOWEN MAXINE | Directior | 2024-06-01 | Option Exercise | 4,660 | 0.00 | 0 | 2024-06-04 16:30:15 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | 2024-04-01 | Option Exercise | 9,467 | 0.00 | 0 | 2024-04-03 17:00:44 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Interim President and CEO | 2024-03-01 | Option Exercise | 9,466 | 0.00 | 0 | 2024-03-05 17:08:09 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2024-03-01 | Option Exercise | 4,975 | 0.00 | 0 | 2024-03-05 17:02:09 |
| ACRS | Aclaris Therapeutics, Inc. | Powell Andrew Kenneth William | Directior | 2024-03-01 | Buy | 14,500 | 1.24 | 17,955 | 2024-03-05 16:58:53 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2024-02-01 | Option Exercise | 7,500 | 0.00 | 0 | 2024-02-05 19:31:24 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2024-02-01 | Option Exercise | 18,750 | 0.00 | 0 | 2024-02-05 19:29:48 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2024-01-01 | Option Exercise | 7,500 | 0.00 | 0 | 2024-01-03 16:47:44 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-10-23 | Sell | 6,000 | 5.08 | 30,460 | 2023-10-25 16:28:41 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2023-09-06 | Buy | 9,490 | 7.90 | 74,971 | 2023-09-07 16:16:48 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2023-09-01 | Option Exercise | 1,000 | 0.00 | 0 | 2023-09-05 17:08:45 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2023-08-28 | Buy | 14,705 | 6.80 | 99,959 | 2023-08-28 16:39:24 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-08-21 | Sell | 6,000 | 7.32 | 43,895 | 2023-08-22 16:31:53 |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | 2023-08-01 | Option Exercise | 15,575 | 0.00 | 0 | 2023-08-03 16:24:53 |
| ACRS | Aclaris Therapeutics, Inc. | Cawkwell Gail | Chief Medical Officer | 2023-07-01 | Option Exercise | 15,000 | 0.00 | 0 | 2023-07-05 16:23:25 |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Directior | 2023-06-20 | Option Exercise | 16,500 | 1.41 | 23,265 | 2023-06-22 16:32:22 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-06-20 | Sell | 6,000 | 10.28 | 61,663 | 2023-06-22 16:30:05 |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Directior | 2023-06-15 | Option Exercise | 249 | 1.36 | 338 | 2023-06-20 16:31:10 |
| ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 17:12:17 |
| ACRS | Aclaris Therapeutics, Inc. | MILANO VINCENT | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 17:08:13 |
| ACRS | Aclaris Therapeutics, Inc. | GOWEN MAXINE | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 17:04:19 |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 17:02:01 |
| ACRS | Aclaris Therapeutics, Inc. | Reasons Bryan M. | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 16:57:56 |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 16:53:44 |
| ACRS | Aclaris Therapeutics, Inc. | Powell Andrew Kenneth William | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 16:50:10 |
| ACRS | Aclaris Therapeutics, Inc. | Mehra Anand | Directior | 2023-06-01 | Option Exercise | 4,507 | 0.00 | 0 | 2023-06-05 16:45:45 |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | 2023-03-17 | Buy | 6,300 | 7.86 | 49,532 | 2023-03-17 17:03:45 |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | 2023-03-09 | Buy | 6,500 | 7.74 | 50,278 | 2023-03-09 17:56:40 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Directior | 2023-03-01 | Sell | 59,240 | 12.50 | 740,658 | 2023-03-03 20:37:20 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Directior | 2023-03-01 | Option Exercise | 156,679 | 0.00 | 0 | 2023-03-03 20:37:20 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-03-01 | Sell | 30,837 | 12.51 | 385,639 | 2023-03-03 20:12:48 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-03-01 | Option Exercise | 87,175 | 0.00 | 0 | 2023-03-03 20:12:48 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2023-03-01 | Sell | 1,894 | 12.45 | 23,579 | 2023-03-03 20:09:46 |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | 2023-03-01 | Option Exercise | 6,450 | 0.00 | 0 | 2023-03-03 20:09:46 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2023-02-15 | Sell | 5,000 | 13.06 | 65,311 | 2023-02-17 16:34:15 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2023-02-08 | Sell | 4,267 | 13.89 | 59,272 | 2023-02-10 16:55:20 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Directior | 2023-02-01 | Sell | 30,000 | 16.66 | 499,923 | 2023-02-03 17:09:17 |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | 2023-02-01 | Option Exercise | 11,250 | 0.00 | 0 | 2023-02-03 17:01:21 |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Directior | 2023-01-03 | Sell | 40,000 | 15.11 | 604,556 | 2023-01-04 18:20:05 |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | 2022-12-15 | Sell | 5,000 | 15.88 | 79,412 | 2022-12-16 16:57:26 |
